Skip to content

Clinical trials

Phase 2 Cardiovascular Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 2 Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20161
20171
20191
20211
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Affiliated Hospital to Academy of Military Medical Sciences1
Beijing University of Chinese Medicine1
Central South University1
Eli Lilly and Company1
Novartis Pharmaceuticals1
Peking Union Medical College1
Pfizer1
Sun Yat-sen University1
Tianjin Medical University General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases9
Atherosclerosis2
Cerebrovascular Disorders2
Dyslipidemias2
Hyperlipidemias2
Stroke2
Angina, Stable1
Angina, Unstable1
Blood Protein Disorders1
Brain Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.